West Pharma (WST) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $390.20 +4.01%
EPS Growth %: -34.3%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
SEIC, OSBC, USAP, More
EPS Growth %: -34.3%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
SEIC, OSBC, USAP, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $368.9 million versus the consensus estimate of $368.6 million.
West Pharmaceutical Services, Inc. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Equity Residential (EQR) Tops Q1 EPS by 44c; offers guidance
- Enphase Energy tumbles on guidance miss; BMO trims estimates and price target
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
